Results for tag: "Hodgkin Lymphoma"

Hodgkin Lymphoma (HL) is a type of cancer that affects the lymphatic system, a part of the immune system. It is characterized by the presence of a type of cell called the Reed-Sternberg cell. HL is the most common type of lymphoma in the United States, and is most common in young adults. Treatment for HL typically involves chemotherapy, radiation therapy, and/or stem cell transplantation. The oncology market for HL is highly competitive, with a number of companies offering treatments and therapies. These include pharmaceutical companies such as AbbVie, Bristol-Myers Squibb, and Merck; biotechnology companies such as Gilead Sciences and Celgene; and medical device companies such as Medtronic and Stryker. Show Less Read more